News Detail
Teaxas, 24 Nov 2021: Since the first checkpoint inhibitor drugs were developed for the treatment of cancer about a decade ago, investigators have focused on ways to make them more effective. A study appearing November 24 in the journal Cancer Cell reports that the o......
View Details
Source : EurekAlert!
Related News
- Engineered peptides open new avenue for immunotherapy drug development (20-04-2024)
- Researchers resolve old mystery of how phages disarm pathogenic bacteria (16-04-2024)
- Carbon beads help restore healthy gut microbiome and reduce liver disease progression (15-04-2024)
- New microfluidic device improves the separation of tumor cells and clusters from malignant effusions (15-04-2024)
- AI makes retinal imaging 100 times faster than manual method (14-04-2024)
- Beta-blockers show no benefit for heart attack patients with normal heart function (11-04-2024)
- GLP-1 analogs not linked to thyroid cancer risk, study finds (11-04-2024)
- Post-surgery infections may mainly be caused by skin bacteria (11-04-2024)
- Many cancer drugs remain unproven 5 yrs after accelerated app (08-04-2024)
- Gut bacteria linked to younger colon cancer patients (08-04-2024)